Web Results

Plerixafor - Wikipedia

en.wikipedia.org/wiki/Plerixafor

Plerixafor is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients ... ball-and-stick model.png. Clinical data. Trade names, Mozobil.

Mozobil

www.mozobil.com/

Official site from Genzyme Corporation. Contains consumer and prescribing information.

Dosing and Administration | Mozobil (plerixafor injection)

www.mozobil.com/healthcare/dosing_and_administration

Learn more about Mozobil (plerixafor injection).The Mozobil Professional website is designed to help healthcare professionals care for their patients with ...

Administration and Timing | Mozobil (plerixafor injection)

www.mozobil.com/patient/administration_and_timing

Your doctor will provide you with detailed instructions about the administration of Mozobil (plerixafor injection) for your stem cell mobilization.

Common Side Effects of Mozobil (Plerixafor Injection) Drug Center ...

www.rxlist.com/mozobil-side-effects-drug-center.htm

Aug 27, 2015 ... Find a comprehensive guide to possible side effects including common and rare side effects when taking Mozobil (Plerixafor Injection) for ...

Mozobil (plerixafor) injection label - FDA

www.accessdata.fda.gov/drugsatfda_docs/label/2010/022311s001lbl.pdf

MOZOBIL. MOZOBIL (plerixafor injection), Solution for Subcutaneous use ... Initiate Mozobil treatment after the patient has received G-CSF once daily for 4 days.

Mozobil : EPAR - European Medicines Agency - Europa

www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001030/WC500030686.pdf

Mozobil 20 mg/ml solution for injection. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION. One ml of solution contains 20 mg plerixafor. Each vial contains  ...

MOZOBIL® (plerixafor) Injection, for subcutaneous use Prescribing ...

products.sanofi.us/Mozobil/mozobil.html

Mozobil, a hematopoietic stem cell mobilizer, is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells ...

Mozobil New FDA Drug Approval | CenterWatch

www.centerwatch.com/drug-information/fda-approved-drugs/drug/1009/mozobil-plerixafor-injection

Mozobil (plerixafor injection): For the treatment of non-Hodgkin's lymphoma and multiple myeloma. New approved drug details including side effects, uses and ...

FDA Approves Genzyme's Mozobil | Sanofi Genzyme News

news.genzyme.com/press-release/fda-approves-genzymes-mozobil

Dec 15, 2008 ...Mozobil is an important advancement in the treatment of patients with certain types of cancer who require a stem cell transplant,” said John F.

More Info

Why Mozobil? | Mozobil (plerixafor injection)

www.mozobil.com

Mozobil (plerixafor injection) is approved by the United States Food and Drug Administration (FDA) to be used with another agent, granulocyte-colony ...

Mozobil (plerixafor) Uses, Dosage, Side Effects - Drugs.com

www.drugs.com

Mozobil helps patients with non-Hodgkin's lymphoma by releasing stem cells that can be collected and transplanted back. Learn about side effects, interactions ...

Mozobil (Plerixafor Injection): Side Effects, Interactions, Warning ...

www.rxlist.com

Mozobil (plerixafor injection) is a sterile, preservative-free, clear, colorless to pale yellow, isotonic solution for subcutaneous injection. Each mL of the sterile ...